Compare OWLS & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OWLS | FLGT |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.9M | 511.0M |
| IPO Year | 2024 | 2016 |
| Metric | OWLS | FLGT |
|---|---|---|
| Price | $5.62 | $19.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $11.00 | ★ $28.33 |
| AVG Volume (30 Days) | 21.7K | ★ 284.7K |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $18,730,000.00 |
| Revenue This Year | $6.57 | $10.09 |
| Revenue Next Year | $375.69 | $12.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.10 | $13.46 |
| 52 Week High | $29.00 | $31.04 |
| Indicator | OWLS | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 56.85 |
| Support Level | $5.56 | $19.20 |
| Resistance Level | $5.78 | $19.85 |
| Average True Range (ATR) | 0.18 | 0.69 |
| MACD | 0.03 | 0.11 |
| Stochastic Oscillator | 82.74 | 82.48 |
OBOOK Holdings Inc operate as a blockchain-powered technology company. It provides solutions across three main business segments: payments, hospitality, and e-commerce, serving businesses and individuals whose commercial activities involve cross-border transactions. The company has five reportable segments: Payment service provides payment solutions to customers, including payment gateway services and payout services; Hospitality-related software services provide the subscription to the OwlNest PMS and the add-on room fee collection services offered to the clients using OwlNest; Hospitality-related platform services that provide an OTA platform and offline platform services offering accommodation services; The E-commerce platform engages in selling products online; and Other services.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.